CClinicalTrials.gg
CompletedNCT04188210Updated Dec 5, 2019

Elbow Pain in Hemodialysis Patients and Its Effect on Daily Living Activities of the Patients

An observational study in End Stage Renal Disease, sponsored by Namik Kemal University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-12-05.

Sponsored by Namik Kemal University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
135
Ages
18 Years and older
Sex
All
01

Study summary

The study will include the patients undergoing hemodialysis.

Read the detailed description

The study will include the patients undergoing hemodialysis. The patients with surgery at upper extremity in last 3 months, the presence of conditions such as cancer, chronic hearing loss and neurologic diseases affect the interview will be excluded. Sociodemographic properties which include age, gender, duration of dialysis, educational level, comorbid diseases, vascular access area, hand dominancy will be asked. The Beck Depression Inventory (BDI), the Nottingham Health Profile (NHP), the Disabilities of the Arm, Shoulder and Hand Score (Q-DASH) and Visual Analogue Scale (VAS) will applied to all patients.

All the demographic results and vascular access area for hemodialysis will be detected. All data for normality will be tested by using Kolmogorov-Smirnov test. To compare the differences between groups, Mann Whitney U test will be used

02

Conditions studied

  • End Stage Renal Disease

Keywords

  • musculoskeletal pain
  • elbow pain
  • hemodialysis
03

In context

Kidney Failure, Chronic

2,085 studies on the registry are indexed under Kidney Failure, Chronic; 260 are open to participants now.

This study's enrollment of 135 is above the median of 120 across 431 observational studies indexed under Kidney Failure, Chronic.

Browse Kidney Failure, Chronic studies →

Lead sponsor

Namik Kemal University is the lead sponsor of 57 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

the patients with end stage renal disease

Inclusion criteria

  • being over 18 years old having hemodialysis treatment

Exclusion criteria

Exclusion Criteria:

  • any surgical operation at upper extremity in last 3 months, the presence of conditions such as cancer, chronic hearing loss and neurologic diseases can affect the interview.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
135 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • OtherPresence of elbow pain in patients with end stage renal disease

    The Beck Depression Inventory (BDI), the Nottingham Health Profile (NHP) scores were measured for all patients to evaluate depression symptoms and health-related quality of life. The elbow pain presence was asked to all the patients, the patients with elbow pain were also evaluated with The Disabilities of the Arm, Shoulder and Hand Score (Q-DASH) and Visual Analogue Scale (VAS). VAS detected as pain during rest, activity, night and pain at last week.

06

What researchers measure

Primary outcomes

  1. Kolmogorov-Smirnov test

    All data for normality was tested by using Kolmogorov-Smirnov test

    Time frame: through study completion, an average of 1 month

07

Study locations

1 site
  • Private Balkan Hospital
    Kırklareli, 39750, Turkey
08

References and documents

Publications

  • Fidan F, Alkan BM, Tosun A, Altunoglu A, Ardicoglu O. Quality of life and correlation with musculoskeletal problems, hand disability and depression in patients with hemodialysis. Int J Rheum Dis. 2016 Feb;19(2):159-66. doi: 10.1111/1756-185X.12171. Epub 2013 Oct 31. PubMed 24176031 ↗
  • Kane SF, Lynch JH, Taylor JC. Evaluation of elbow pain in adults. Am Fam Physician. 2014 Apr 15;89(8):649-57. PubMed 24784124 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04188210
Lead sponsor
Namik Kemal University
Responsible party
Betül Tepeli (Department of Physical Medicine And Rehabilitation, Private Balkan Hospital,Principal Investigator,, Namik Kemal University) — Principal investigator
First posted
Dec 5, 2019
Start date
Mar 1, 2019
Primary completion
Apr 1, 2019
Completion
Apr 1, 2019
Last update
Dec 5, 2019

Study contacts

betül tepeli
principal investigator · private balkan hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion